UBS Lux Equity Fund Biotech USD vs Evli High Yield

UBS Lux Equity Fund Biotech USD vs Evli High Yield

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

2. Evli High Yield

  • Security

    Evli High Yield B

  • Fee

    1.11%

  • ISIN

    FI0008803929

  • Holdings

    16

Fund Holdings

We have information about 11 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Vertex (8.44). In comparison with Evli High Yield, we have 16 holdings where Iliad Holding is the largest holding (1.37), followed by Lorca Telecom Bondco (1.36) and BPCE (1.27).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Evli High Yield.

UBS Lux Equity Fund Biotech USD Evli High Yield
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Iliad Holding SAS
France
1.37 %
2. Moderna Inc
9.21 %
2. Lorca Telecom Bondco SAU
Spain
1.36 %
3. Vertex Pharmaceuticals Inc
8.44 %
3. BPCE SA
France
1.27 %
4. Alnylam Pharmaceuticals Inc
8.08 %
4. Allianz SE
Germany
1.16 %
5. AbbVie Inc
USA
4.91 %
5. Commerzbank AG
Germany
1.1 %
6. Gilead Sciences Inc
USA
4.66 %
6. Zegona Finance Plc
UK
1.08 %
7. Amgen Inc
USA
4.43 %
7. Dynamo Newco II GmbH
Germany
1.05 %
8. BioNTech SE
4.13 %
8. Nidda Healthcare Holding GmbH
Germany
1.05 %
9. Karuna Therapeutics Inc
3.75 %
9. Telefónica Europe BV
Netherlands
1.02 %
- 10. UPCB Finance VII Ltd
Cayman Islands
1.02 %
- 11. Progroup AG
Switzerland
1 %
- 12. Fabbrica Italiana Sintetici SpA
Italy
1 %
- 13. Intrum AB
0.98 %
- 14. NTI Group Holding ApS
Denmark
0.98 %
- 15. Boels Topholding NV
Netherlands
0.95 %
- 16. Eroski Sociedad Cooperativa
Spain
0.92 %

The list of fund holdings was last updated on July 25, 2025.